相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett et al.
CIRCULATION (2019)
Heart Disease and Stroke Statistics-2019 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2019)
SuPAR, an emerging biomarker in kidney and inflammatory diseases
Lamiaa Hamie et al.
POSTGRADUATE MEDICAL JOURNAL (2018)
Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease
Eunsil Hahm et al.
NATURE MEDICINE (2017)
A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease
Salim S. Hayek et al.
NATURE MEDICINE (2017)
Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death
Nima Ghasemzadeh et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2017)
Cohort profile: the Emory Cardiovascular Biobank (EmCAB)
Yi-An Ko et al.
BMJ OPEN (2017)
Negative regulation of urokinase receptor activity by a GPI-specific phospholipase C in breast cancer cells
Michiel van Veen et al.
ELIFE (2017)
Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure
Lorenz Koller et al.
JACC-HEART FAILURE (2017)
Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes
Ayman Samman Tahhan et al.
ATHEROSCLEROSIS (2017)
Sex-Based Differences in Cardiometabolic Biomarkers
Jeanney Lew et al.
CIRCULATION (2017)
Novel Biomarker of Oxidative Stress Is Associated With Risk of Death in Patients With Coronary Artery Disease
Riyaz S. Patel et al.
CIRCULATION (2016)
Atherothrombotic Risk Stratification and the Efficacy and Safety of Vorapaxar in Patients With Stable Ischemic Heart Disease and Previous Myocardial Infarction
Erin A. Bohula et al.
CIRCULATION (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Involvement of urokinase receptor in the cross-talk between human hematopoietic stem cells and bone marrow microenvironment
Carmine Selleri et al.
ONCOTARGET (2016)
Plasma soluble urokinase-type plasminogen activator receptor level is independently associated with coronary microvascular function in patients with non-obstructive coronary artery disease
Girum Mekonnen et al.
ATHEROSCLEROSIS (2015)
Soluble Urokinase Receptor and Chronic Kidney Disease
Salim S. Hayek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Leptin, IL-6, and suPAR reflect distinct inflammatory changes associated with adiposity, lipodystrophy and low muscle mass in HIV-infected patients and controls
Anne Langkilde et al.
IMMUNITY & AGEING (2015)
Soluble urokinase plasminogen activator receptor is in contrast to high-sensitive C-reactive-protein associated with coronary artery calcifications in healthy middle-aged subjects
Mette Hjortdal Sorensen et al.
ATHEROSCLEROSIS (2014)
Unchanged Plasma Levels of the Soluble Urokinase Plasminogen Activator Receptor in Elective Coronary Artery Bypass Graft Surgery Patients and Cardiopulmonary Bypass Use
Waldemar Gozdzik et al.
PLOS ONE (2014)
Soluble Urokinase Plasminogen Activator Receptor Level Is an Independent Predictor of the Presence and Severity of Coronary Artery Disease and of Future Adverse Events
Danny J. Eapen et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
A Longitudinal Study of Health Improvement in the Atlanta CHDWB Wellness Cohort
Rubina Tabassum et al.
JOURNAL OF PERSONALIZED MEDICINE (2014)
Cardiovascular risk prediction in the general population with use of suPAR, CRP, and Framingham Risk Score
Stig Lyngbaek et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Aggregate Risk Score Based on Markers of Inflammation, Cell Stress, and Coagulation Is an Independent Predictor of Adverse Cardiovascular Outcomes
Danny J. Eapen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Usefulness of Soluble Urokinase Plasminogen Activator Receptor to Predict Repeat Myocardial Infarction and Mortality in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention
Stig Lyngbaek et al.
AMERICAN JOURNAL OF CARDIOLOGY (2012)
Impaired Coronary Flow Reserve as a Marker of Microvascular Dysfunction to Predict Long-Term Cardiovascular Outcomes, Acute Coronary Syndrome and the Development of Heart Failure
Koki Nakanishi et al.
CIRCULATION JOURNAL (2012)
Third universal definition of myocardial infarction
Kristian Thygesen et al.
EUROPEAN HEART JOURNAL (2012)
Circulating soluble urokinase plasminogen activator receptor predicts cancer, cardiovascular disease, diabetes and mortality in the general population
J. Eugen-Olsen et al.
JOURNAL OF INTERNAL MEDICINE (2010)
Predictive Health: The Imminent Revolution in Health Care
Kenneth L. Brigham
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2010)
Association of serum amyloid A levels with adipocyte size and serum levels of adipokines: Differences between men and women
Kajsa Sjoholm et al.
CYTOKINE (2009)
Sex Differences in the Relationship between C-Reactive Protein and Body Fat
Amit Khera et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction The Reynolds Risk Score for Men
Paul M. Ridker et al.
CIRCULATION (2008)
Modification of kidney barrier function by the urokinase receptor
Changli Wei et al.
NATURE MEDICINE (2008)
Sex differences in monocyte expression of IL-6: role of autonomic mechanisms
Mary-Frances O'Connor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2007)
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women - The Reynolds Risk Score
Paul M. Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Structure of human urokinase plasminogen activator in complex with its receptor
Q Huai et al.
SCIENCE (2006)
Sex differences in the relation of body composition to markers of inflammation
B Thorand et al.
ATHEROSCLEROSIS (2006)
UPA and uPAR in fibrinolysis, immunity and pathology
A Mondino et al.
TRENDS IN IMMUNOLOGY (2004)
Inflammation as a cardiovascular risk factor
JT Willerson et al.
CIRCULATION (2004)